Correlation Between Biotechnology Fund and Nasdaq-100 Fund

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotechnology Fund and Nasdaq-100 Fund at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Fund and Nasdaq-100 Fund into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Fund Class and Nasdaq 100 Fund Class, you can compare the effects of market volatilities on Biotechnology Fund and Nasdaq-100 Fund and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Fund with a short position of Nasdaq-100 Fund. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Fund and Nasdaq-100 Fund.

Diversification Opportunities for Biotechnology Fund and Nasdaq-100 Fund

0.83
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Biotechnology and Nasdaq-100 is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Fund Class and Nasdaq 100 Fund Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nasdaq 100 Fund and Biotechnology Fund is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Fund Class are associated (or correlated) with Nasdaq-100 Fund. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nasdaq 100 Fund has no effect on the direction of Biotechnology Fund i.e., Biotechnology Fund and Nasdaq-100 Fund go up and down completely randomly.

Pair Corralation between Biotechnology Fund and Nasdaq-100 Fund

Assuming the 90 days horizon Biotechnology Fund Class is expected to under-perform the Nasdaq-100 Fund. In addition to that, Biotechnology Fund is 1.57 times more volatile than Nasdaq 100 Fund Class. It trades about -0.12 of its total potential returns per unit of risk. Nasdaq 100 Fund Class is currently generating about -0.02 per unit of volatility. If you would invest  5,962  in Nasdaq 100 Fund Class on November 1, 2024 and sell it today you would lose (186.00) from holding Nasdaq 100 Fund Class or give up 3.12% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy98.33%
ValuesDaily Returns

Biotechnology Fund Class  vs.  Nasdaq 100 Fund Class

 Performance 
       Timeline  
Biotechnology Fund Class 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotechnology Fund Class has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's technical and fundamental indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.
Nasdaq 100 Fund 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nasdaq 100 Fund Class has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Nasdaq-100 Fund is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Biotechnology Fund and Nasdaq-100 Fund Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotechnology Fund and Nasdaq-100 Fund

The main advantage of trading using opposite Biotechnology Fund and Nasdaq-100 Fund positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Fund position performs unexpectedly, Nasdaq-100 Fund can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nasdaq-100 Fund will offset losses from the drop in Nasdaq-100 Fund's long position.
The idea behind Biotechnology Fund Class and Nasdaq 100 Fund Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
FinTech Suite
Use AI to screen and filter profitable investment opportunities